SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-18-052661
Filing Date
2018-08-17
Accepted
2018-08-17 17:06:31
Documents
4
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a18-18618_110ka.htm 10-K/A 191871
2 EX-31.1 a18-18618_1ex31d1.htm EX-31.1 12925
3 EX-31.2 a18-18618_1ex31d2.htm EX-31.2 12893
4 EX-32.1 a18-18618_1ex32d1.htm EX-32.1 8049
  Complete submission text file 0001104659-18-052661.txt   226764
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37719 | Film No.: 181026429
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences